Details for New Drug Application (NDA): 009052
✉ Email this page to a colleague
The generic ingredient in REZIPAS is aminosalicylic acid resin complex. There are fifteen drug master file entries for this compound. Additional details are available on the aminosalicylic acid resin complex profile page.
Summary for 009052
Tradename: | REZIPAS |
Applicant: | Bristol Myers Squibb |
Ingredient: | aminosalicylic acid resin complex |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;ORAL | Strength | EQ 500MG BASE/GM | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription